Anton Pozniak

Pharmacokinetics and Safety of Saquinavir/Ritonavir and Omeprazole in HIV‐infected Subjects

B. Gazzard, C. Fletcher, M. Boffito, 2008, Clinical pharmacology and therapeutics.

Screening for HIV-related neurocognitive impairment in clinical practice: Challenges and opportunities

J. Catalan, M. Boffito, B. Gazzard, 2014, AIDS care.

Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study

B. Gazzard, G. Moyle, D. Asboe, 2017, International journal of STD & AIDS.

Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction

C. Fraser, E. Volz, D. Pillay, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.